— Know what they know.
Not Investment Advice
Also trades as: 9688.HK (HKSE) · $vol 19M

ZLAB NASDAQ

Zai Lab Limited
1W: -6.0% 1M: -8.2% 3M: +28.8% YTD: +36.1% 1Y: -10.4% 3Y: -1.4% 5Y: -76.7%
$23.58
-0.76 (-3.12%)
After Hours: $23.29 (-0.29, -1.25%)
Weekly Expected Move ±9.6%
$19 $22 $24 $26 $29
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 47 · $2.6B mcap · 105M float · 0.934% daily turnover · Short 50% of daily vol
Credit Risk of going bust: lower than 51% of companies Debt: 8.5% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.43 (down 98%), Zai Lab Limited would be worth roughly what it owes.
Total debt $254.6M against a stock market value of $2.73B.
Distance to default 5.22 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $238.1M (short-term plus half of long-term), stock volatility 50.9%; Altman Z'' -5.11. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Balance Sheet Trends

Total Assets
$1.2B -1.1% ▼
5Y CAGR: -2.0%
Total Liabilities
$457M +32.5% ▲
5Y CAGR: +28.9%
Shareholders Equity
$716M -14.9% ▼
5Y CAGR: -9.4%
Cash & Investments
$690M -11.6% ▼
5Y CAGR: -10.3%
Total Debt
$224M +46.1% ▲
5Y CAGR: +64.5%
Net Debt
-$455M -53.7% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$964M$1.0B$790M$450M$680M
Short-Term Investments$445M$0$16M$330M$10M
Cash & ST Investments$1.4B$1.0B$806M$780M$690M
Net Receivables$55M$49M$65M$89M$106M
Inventory$19M$32M$45M$40M$75M
Other Current Assets$0$36M$23M$142M$149M
Total Current Assets$1.5B$1.1B$940M$1.1B$1.0B
Property, Plant & Equip.$58M$79M$69M$69M$67M
Goodwill & Intangibles$10M$8M$16M$59M$76M
Long-Term Investments$16M$6M$9M$3M$0
Other Non-Current Assets$26M$2M$2M$4M$7M
Total Non-Current Assets$109M$96M$97M$135M$153M
Total Assets$1.6B$1.2B$1.0B$1.2B$1.2B
— Liabilities —
Accounts Payable$126M$66M$113M$101M$142M
Short-Term Debt$0$0$0$132M$211M
Deferred Revenue$0$0$0$0$27M
Other Current Liabilities$4M$4M$5M$6M$36M
Total Current Liabilities$193M$140M$203M$299M$416M
Long-Term Debt$0$0$0$0$13M
Other Non-Current Liab.$0$0$325K$325K$27M
Total Non-Current Liabilities$37M$35M$37M$45M$41M
Total Liabilities$230M$175M$240M$345M$457M
— Equity —
Common Stock$6K$6K$6K$7K$7K
Retained Earnings-$1.4B-$1.9B-$2.2B-$2.5B-$2.6B
Accumulated OCI-$24M$26M$38M$51M$30M
Total Stockholders Equity$1.4B$1.0B$796M$841M$716M
Total Liabilities & Equity$1.6B$1.2B$1.0B$1.2B$1.2B
— Key Metrics —
Total Debt$16M$20M$15M$153M$224M
Net Debt-$949M-$988M-$775M-$296M-$455M
Total Investments$461M$6M$26M$333M$10M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms